Froedtert Hospital and the Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
Location status: Recruiting
Location contact
Kelly Rentscher, PhD
CONTACT
Kelly Rentscher, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT04892823
This project aims to elucidate the important protective elements of social relationships and identify concrete, modifiable behavioral factors that contribute to biological and phenotypic aging in hematopoietic cell transplantation (HCT) survivors and can be used to develop biologically informed interventions to improve quality of life and prolong the healthspan of individuals with accelerated aging.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Milwaukee, Wisconsin, 53226, United States
Location status: Recruiting
Kelly Rentscher, PhD
CONTACT
Kelly Rentscher, PhD
PRINCIPAL_INVESTIGATOR
PRIMARY OBJECTIVES:
I. Examine associations between social support, strain, and isolation and phenotypic aging over the 1-year recovery period.
II. Examine associations between social support, strain, and isolation and biological aging over the 1-year recovery period.
III. Test biological aging as a mediator linking social processes and phenotypic aging.
EXPLORATORY OBJECTIVE:
I. Test sex differences in Aims 1 and 2.
OUTLINE:
Adopting a prospective design, participants will complete comprehensive assessments of social processes at 100 days and 1 year after HCT that combine reports of social support, strain, and isolation with a naturalistic observation tool, the Electronically Activated Recorder (EAR), which captures ambient sound bites to assess social interactions in survivors' daily lives16. At each time point, participants will also provide reports of symptoms to characterize phenotypic aging, including cognitive, physical, and functional complaints, and blood samples to assess biological aging, including cellular senescence, DNA damage, SASP, and cellular stress using genome-wide RNA sequencing. Relevant clinical information that could influence biological aging will also be collected from patients' medical records to consider as covariates.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Undergo collection of blood sample
Review of medical records
Complete questionnaires
Time frame: Day 100 and 1 year post-transplant
This will be measured by mRNA/gene expression.
Contact information is provided by the study sponsor or research team.
Medical College of Wisconsin
Other
Accelerated Biological and Phenotypic Aging in Hematopoietic Cell Transplant Survivors: Social Support as a Protective Factor
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04744116
Hematologic Diseases, Hematologic Neoplasms
Houston, Texas, United States
View Trial DetailsNCT04712539
Hematologic Diseases, Hematologic Neoplasms
Houston, Texas, United States
View Trial DetailsNCT05334069
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Anchorage, Alaska, United States
View Trial DetailsNCT03670966
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Seattle, Washington, United States
View Trial Details